Publications by authors named "Christos Papandreou"

Claim this Profile
E
Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece.
Evangelos Bournakis, Ioannis Xanthakis, Michail Vaslamatzis, Parisis Makrantonakis, Charisios Karanikiotis, Christos Papandreou

Anticancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis: The Postchemotherapy Open RPLND Experience.
Konstantinos Dimitropoulos, Louis L Pisters, Christos N Papandreou, Danai Daliani, Anastasios Karatzas

Curr Cancer Drug Targets· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
Athina Christopoulou, Alexandros Ardavanis, Christos Papandreou, Georgios Koumakis, Georgios Papatsimpas

Oncol Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.
Manish A Shah, Anghel Adrian Udrea, Igor Bondarenko, Was Mansoor, Raquel Guardeño Sánchez, Christos Papandreou

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study).
Michalis Liontos, Eleni Timotheadou, Emmanuel I Papadopoulos, Zafeiris Zafeiriou, Dimitra Ioanna Lampropoulou, Christos Papandreou

Curr Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis.
Panagiotis J Vlachostergios, Athanasios Karathanasis, Christos N Papandreou, Vassilios Tzortzis

World J Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
Dimitrios P Bogdanos, Athanasios Gkoutzourelas, Vasilios Papadopoulos, Christos Liaskos, Eleni Patrikiou, Christos Papandreou

Clin Chim Acta· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer.
Lampros Mitrakas, Stavros Gravas, Foteini Karasavvidou, Ioannis Zachos, Anastasios Karatzas, Christos Papandreou

Arch Ital Urol Androl· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF-2 and HGF reverse abiraterone's effect οn intracellular levels of DHT in androgen-dependent and androgen independent prostate cancer cell lines.
Chrysoula Vasileiou, Christina Befani, Konstantinos Dimas, Panagiotis Liakos, Christos Papandreou

J BUON· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Nikolaos Tsoukalas, Pavlos Papakotoulas, Athina Christopoulou, Alexandros Ardavanis, Georgios Koumakis, Christos Papandreou

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.
Pavlos Papakotoulas, Nikolaos Tsoukalas, Athina Christopoulou, Alexandros Ardavanis, Georgios Koumakis, Christos Papandreou

Anticancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in Greece.
Ioannis Boukovinas, Athanasios Kotsakis, Nikolaos Androulakis, Gerasimos Aravantinos, Vasiliki Michalaki, Christos Papandreou

Anticancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis.
Eleni Isidora A Perdikouri, Kostoula Arvaniti, Dimitrios Lathyris, Fani Apostolidou Kiouti, Eleni Siskou, Christos Papandreou

Microorganisms· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model.
Konstantinos Kamposioras, Chrysiida Tsimplouli, Caroline Verbeke, Alan Anthoney, Argyro Daoukopoulou, Christos N Papandreou

Int J Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary High-Grade Non-Muscle-Invasive Bladder Cancer: High NFκB Expression in Tumor Specimens Distinguishes Patients Who are at Risk for Disease Progression.
Lampros Mitrakas, Stavros Gravas, Christos Papandreou, Georgios Koukoulis, Foteini Karasavvidou

Pathol Oncol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primitive neuroectodermal tumor transformation of testicular teratoma.
Anastasios Karatzas, Vasileios Papadopoulos, Vagianna Katsiouli, Louis Pisters, Christos Papandreou

Urol Ann· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Christos Christodoulou, Anna Kalogera-Fountzila, Vasilios Karavasilis, George Kouvatseas, Christos N Papandreou

J Neurooncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients.
Michalis Liontos, Eleni-Andriana Trigka, Penelope Korkolopoulou, Kimon Tzannis, Giorgos Lainakis, Christos N Papandreou

World J Urol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.
Jorge A Marrero, Masatoshi Kudo, Alan P Venook, Sheng-Long Ye, Jean-Pierre Bronowicki, Christos Papandreou

J Hepatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.
Maria Vaiou, Evanthia Pangou, Panagiotis Liakos, Nikos Sakellaridis, George Vassilopoulos, Christos Papandreou

J Cancer Res Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
Masatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, Alan P Venook, Jean-Pierre Bronowicki, Christos Papandreou

Liver Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
Vassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, George Kouvatseas, Eleni Giannoulatou, Christos Papandreou

Breast Cancer Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer.
Vassilis Papadopoulos, Konstantinos Tsapakidis, Natalia A Riobo Del Galdo, Christos N Papandreou, Francesco Del Galdo

Clin Colorectal Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.
Jean-François Geschwind, Masatoshi Kudo, Jorge A Marrero, Alan P Venook, Xiao-Ping Chen, Christos Papandreou

Radiology· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
George Fountzilas, Eleni Giannoulatou, Zoi Alexopoulou, Flora Zagouri, Eleni Timotheadou, Christos Papandreou

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis